Global SPECT & SPECT-CT Market Size - Forecast to 2026
Global SPECT & SPECT-CT Market Size - Forecast to 2026
According to a new market research report published by Global Market Estimates, the Global SPECT & SPECT-CT Market is projected to grow from USD 1.4 billion in 2021 to USD 2.9 billion by 2026 at a CAGR value of 5.6% from 2021 to 2026.
Rapid growth in early diagnostic techniques, the broadening scope of therapeutic trials, rapidly rising geriatric population and the resulting increase in the prevalence of chronic disorders, technological innovations in the medical diagnostic industry, and the boost to investments, financing, and subsidies by public-private organizations are all driving the market forward during the forecast period.
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global SPECT & SPECT-CT Market - Forecast to 2026"
https://www.globalmarketestimates.com/market-report/spect-spect-ct-market-3618
By Product Type (Standalone SPECT System, Hybrid SPECT (SPECT-CT & SPECT-PET) System), By Application (Oncology, Cardiology, Neurology, Other Applications), By Type of Radioisotopes (Tc-99m, Ra-223, Ga-66, I-123, Other Types of Radioisotopes), By End-User (Hospitals & Multi-specialty Clinics, Diagnostic Imaging Center, Research & Academic Institutes, Other End-Users), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis
Key Market Insights
- As per the product type outlook, the hybrid SPECT (SPECT-CT & SPECT-PET) system segment is expected to have the largest share in the market due to enhanced localization, and the capability to distinguish physiologic from pathologic processes
- The application of SPECT & SPECT-CT for cardiology is expected to have the largest share in the market during the forecast period as per the application outlook, as SPECT is mostly used in cardiology to determine coronary artery disease
- The Tc-99m segment is anticipated to have the largest share during the forecast period as per the type of radioisotopes outlook, owing to its versatility.
- The hospitals & multi-specialty clinics segment is anticipated to have the largest share due to rising demand for better imaging modalities as per the end-user outlook
- Global Medical Solutions, NTP Radioisotopes SOC Ltd, Cardinal Health Inc, GE Healthcare (GE Company), Spectrum Dynamics Medical, Digirad Corporation, Gamma Medica Inc., Curium, Bracco Imaging, Bruker Corporation, Esaote SpA, Invicro, LLC, Mediso Medical Imaging Systems, MR Solutions Ltd., Philips Healthcare, among others, are the key players in the SPECT & SPECT-CT market
Browse the Report @ https://www.globalmarketestimates.com/market-report/spect-spect-ct-market-3618
Product Type Outlook (Revenue, USD Billion, 2021-2026)
- Standalone SPECT System
- Hybrid SPECT (SPECT-CT & SPECT-PET) System
Application Outlook (Revenue, USD Billion, 2021-2026)
- Oncology
- Cardiology
- Neurology
- Other Applications
Type of Radioisotopes Outlook (Revenue, USD Billion, 2021-2026)
- Tc-99m
- Ra-223
- Ga-66
- I-123
- Other Types of Radioisotopes
End-User Outlook (Revenue, USD Billion, 2021-2026)
- Hospitals & Multi-specialty Clinics
- Diagnostic Imaging Center
- Research & Academic Institutes
- Other End-Users
Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of APAC
Central & South America
- Brazil
- Argentina
- Rest of CSA
Middle East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: Global Market Estimates
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php